Artelo Biosciences (NASDAQ: ARTL) announced on Thursday it will effect a 1-for-9 reverse stock split of its common stock, with trading to begin Aug. 31. – No fractional shares will be issued, with holders receiving one whole share instead. – The company said the reverse split…
intended to increase its share price and improve marketability and liquidity. – Pursuant to the transaction, the company expects approximately 547,774 shares of common stock to be outstanding. – Outstanding warrants and other derivatives will automatically adjust to reflect the reverse split. – Share -0.92%